PCOS Is Now PMOS: What the New Name Means for Your Health (and Why It Matters)
Author and Medical Reviewer by NP Julia Standefer August 30, 2026
If you've been diagnosed with polycystic ovary syndrome (PCOS), you may want to know the condition was recently renamed polyendocrine metabolic ovarian syndrome (PMOS) by a global consensus of clinicians, researchers, and patients (Teede et al., 2026). Yes, it took a decade, but it is not a rebrand for the sake of it. It's a correction, and a long-overdue one. One that finally puts the full picture of your health on the table, instead of just the ovary. It is estimated that 10% of all females at birth have it, according to The Endocrine Society. This makes it the most common endocrine condition women have. The Monash Centre for Health Research, the Endocrine Society and the American Society for Reproductive Medicine all agreed on the name change, which attempts to account for the full-body nature of the condition.
Why the Name Changed
"Polycystic ovary syndrome" was always a misleading label. Many people diagnosed with it don't actually have ovarian cysts, and the name kept the conversation narrowly focused on the ovaries, when the condition is really about hormone and metabolic dysregulation that touches your whole body (Shukla et al., 2025). Insulin resistance, weight regulation, cardiovascular risk, irregular periods, skin and hair changes, and mood shifts can all be a part of the same underlying picture, not separate or unrelated complaints.
That's exactly what "polyendocrine" and "metabolic" in PMOS are meant to capture:
Polyendocrine — multiple hormone systems are involved, not just reproductive hormones.
Metabolic — insulin resistance sits at the center for most patients, having adverse effects on weight, blood sugar, and cardiovascular health
For patients, this reframe matters in guiding solutions for this condition. Hormones don’t work in isolation, this same principle. I've written separately about how new FDA labeling changes are reshaping menopausal hormone therapy for exactly this reason.
If your provider has only ever treated your PCOS/PMOS as a "period problem" or a fertility issue, you may be missing care for the metabolic side of the condition. That's where a lot of the long-term health risk actually lives. Your ovaries did not sign up to take the blame for your blood sugar, your skin, and your energy levels all by themselves. It's about time the rest of the body got included in the care plan.
This Is Where Self-Advocacy Comes In
As the patient, you often have to be the one connecting the dots for your medical providers. Symptoms get put into silos: your OB/GYN handles the ovarian piece, your PCP might handle blood sugar, and nobody's looking at the whole system together. It's a bit like three different mechanics each fixing one wheel and no one checking if the car actually drives straight.
You don't have to accept that. My recommendation for items worth mentioning at your next appointment:
Ask specifically about insulin resistance testing, not just a standard glucose panel. (Tip: This is done with the addition of an A1c and fasting insulin.) Having measurable data points helps us track all the progress you have made.
Ask whether your treatment plan addresses metabolic health, not just menstrual regulation.
If you're recommended to lose weight and that has been impossible with prior attempts - ask for a referral to someone who can build a plan with you. A multi-discliplanary approach, i.e. a dietician, coach or weight loss medication all improve your odds of success.
Track your own symptoms (cycle changes, energy, skin, weight trends, mood symptoms) so you're bringing data, not just a list of complaints, into the visit.
Getting properly diagnosed and treated for PMOS often takes more than one visit and more than one specialist. That's normal and it's worth pushing for.
Treatment: Start With What Works, Then Layer In What's Needed
First - Diet and Lifestyle
For most people with PMOS, the foundation is still diet and exercise, and it doesn't have to be complicated. The pattern that consistently helps:
Protein and vegetables at the center of meals
Healthy fats (olive oil, nuts, avocado)
Limited refined carbohydrates and added sugar, which drive the insulin spikes at the root of PMOS symptoms
Exercise, including strength training, improves insulin sensitivity independent of weight loss
This is about correcting the insulin-glucose imbalance that's driving symptoms in the first place.
Second - When Medication Makes Sense
For many patients, lifestyle changes alone aren't enough to fully correct the underlying insulin resistance, though medication can help close that gap:
Metformin is commonly used off-label for PMOS to improve insulin sensitivity and help regulate the glucose-insulin imbalance at the core of the condition. (Legro et al., 2013). (Worth noting: surprisingly, some patients report their menstrual cycles lighten or become more regular with metformin)
GLP-1/GIP medications (semaglutide/Ozempic, tirzepatide/Mounjaro or Zepbound) are also used off-label in PMOS care (Rahim et al. 2025). By reducing appetite, they help correct portion sizes that often creep up gradually and unnoticed — supporting the same metabolic goals as diet changes, from a different angle. This medication class commonly causes nausea and GI upset, especially early on, and aren't right for everyone. This knowledge can help start a conversation, and medications are not a default choice for everyone.
These medications are not a replacement for diet and lifestyle work. They are tools that can make that work more effective when insulin resistance is significant.
The Part That Doesn't Show Up on a Lab Report
Here's the good news, and it's the part that doesn't always make it into the PCOS/PMOS clinical literature: when women work through these changes (diet, movement, and medication when needed) the labs usually improve. But so does everything else.
Ask around, and you'll hear the same patient story on repeat: more energy, less of that mid-afternoon crash, and a noticeable lift in mental clarity; the "brain fog" that so many women with PCOS/PMOS have quietly accepted as normal starts to lift. Patients report their mood tends to even out. Sleep improves. People describe feeling like themselves again, sometimes for the first time in years. None of that shows up on blood work, but patients report it is real and it is often the first thing they notice; and that is usually before the number on the scale even moves.
So no, this isn't just about better insulin sensitivity on paper (although, congratulations in advance to your pancreas for the win), it's also about productivity in your day with something left in the tank by 2pm. That is absolutely a reasonable thing to reach for as you work through treatment.
Next Steps
If you suspect PMOS/ PCOS is affecting more than your cycle — your energy, your mood, your weight, your skin, your bloodwork — it's worth getting a personalized consultation.
Book a nutrition deep-dive with a dietician to work through dietary changes tailored to you, or book a personalized PMOS care plan here at Sanctuary Health to build a plan that actually fits your body and your life.
This content is educational and not a substitute for individualized medical advice. Book an appointment to discuss your specific symptoms and history.
References (accurate as of August 2026):
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: An Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565–4592. doi.org
Rahim S, Pergolizzi J Jr. The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Agonists for Polycystic Ovary Syndrome. Cureus. 2025 Jan 26;17(1):e77998. doi: 10.7759/cureus.77998. PMID: 40007927; PMCID: PMC11852098. https://pmc.ncbi.nlm.nih.gov/articles/PMC11852098/
Shukla A, Rasquin LI, Anastasopoulou C. Polyendocrine Metabolic Ovarian Syndrome. [Updated 2025 Jul 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK459251/
Teede H, Khomami M, Morman R et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet, 2026; 407, 2329-2339. https://www.thelancet.com/journals/lancet/article/PIIS0140-67362600717-8/fulltext
